By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Saudi Arabia accounts for 60 percent of the Gulf Cooperation Council (GCC) countries’ healthcare expenditure, and the sector remains a top priority for the Saudi Arabian Government. The Saudi Arabian Government is targeting the healthcare sector for privatization.
The high burden of disease is driving demand for a wide range of diabetes medical devices, including blood glucose monitoring devices, insulin pumps, continuous glucose monitoring (CGM) systems, and insulin delivery systems.
The increasing prevalence of diabetes in Saudi Arabia is a major driver of market growth. The country’s high rates of obesity, physical inactivity, and unhealthy diet are all contributing to the rising incidence of diabetes.
There is growing awareness of diabetes among the Saudi Arabian population, which is leading to increased demand for diabetes screening and treatment. This awareness is being raised by government initiatives, healthcare providers, and patient advocacy groups.
The Saudi Arabian government is investing heavily in improving the country’s healthcare infrastructure. This includes building new hospitals and clinics, and investing in new medical technologies.
There is a growing trend among people with diabetes to self-monitor their blood glucose levels. This is leading to increased demand for self-monitoring devices, such as blood glucose meters and continuous glucose monitoring (CGM) systems.
There have been significant technological advancements in the field of diabetes medical devices in recent years. These advancements have led to the development of more accurate, reliable, and user-friendly devices, which is further driving demand.
Diabetes is a chronic, metabolic disease characterized by elevated levels of blood glucose (or blood sugar), which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and nerves.
The most common is type 2 diabetes mellitus, usually in adults, which occurs when the body becomes resistant to insulin or doesn’t make enough insulin. Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin by itself.
The main types of diabetes care devices include glucose monitoring devices and management devices. Continuous glucose monitoring devices have become immensely popular due to the rise in technological innovations.
Based on a study by Oxford Economics, Saudi Arabia will have a large segment of its population between the ages of 40 and 59, expected to increase by 50 percent by 2035, which, in turn, will dictate a shift in the provision of healthcare services. That shift will be felt more in providing care for non-communicable diseases, including cardiovascular disease, diabetes, and obesity.
The increasing diabetes population in the country. The diabetes population in Saudi Arabia is expected to reach 8.68 million by 2026.
CGM systems enable real-time monitoring of glucose levels, reducing the need for frequent fingerstick tests and providing timely alerts for potential hypoglycemic or hyperglycemic events.
By embracing these cutting-edge medical devices, Saudi Arabia aims to enhance diabetes care, reduce complications, and alleviate the burden of the disease on both patients and the healthcare system. However, challenges such as accessibility, affordability, and education about these technologies remain critical for ensuring widespread adoption and improved diabetes outcomes across the nation.
The awareness of self-monitoring of glucose levels has increased widely in Saudi Arabia, and the market for monitoring devices is expected to see high growth in the country during the forecast period.
The most prominent work culture perpetuated in the country, which includes sitting for hours in one position and eating fast food with little or no physical activity, is a significant contributor to diabetes in the working-age group, causing this rapid increase in diabetes cases in Saudi Arabia.
Saudi Arabia has the most established regulatory framework, followed by the UAE, and last, Qatar, with its system still in the early stages of development.
The Saudi Arabia diabetes medical device market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
TRENDS IN SAUDI ARABIA DIABETES MEDICAL DEVICE MARKET
Adoption of artificial intelligence (AI) and machine learning (ML) in diabetes management: AI and ML are being increasingly used to develop smart diabetes management devices and applications that can provide personalized insights and recommendations to patients.
For instance, AI-powered insulin pumps can automatically adjust insulin delivery based on real-time glucose data, while ML-based algorithms can help patients identify patterns in their blood glucose levels and make lifestyle modifications accordingly.
Rise of non-invasive glucose monitoring devices: Non-invasive glucose monitoring devices, such as continuous glucose monitoring (CGM) systems and optical glucose monitoring devices, are gaining popularity due to their convenience and ease of use. These devices eliminate the need for finger pricks, making blood glucose monitoring less painful and more manageable for patients.
Integration of diabetes management devices with smartphones and wearables: Diabetes management devices are increasingly being integrated with smartphones and wearable devices, allowing patients to collect, track, and analyze their blood glucose data in a more convenient and user-friendly manner. This integration also enables seamless data sharing with healthcare providers, facilitating better patient care and outcomes.
Remote patient monitoring and telehealth solutions: Remote patient monitoring (RPM) and telehealth solutions are playing a growing role in diabetes management, particularly in rural and underserved areas. These technologies allow healthcare providers to remotely monitor patients’ blood glucose levels, provide real-time consultations, and offer personalized care plans, improving patient outcomes and reducing the need for in-person visits.
Development of closed-loop insulin delivery systems: Closed-loop insulin delivery systems, also known as artificial pancreas systems, are being developed to automate glucose management for patients with type 1 diabetes. These systems combine a CGM system with an insulin pump and use algorithms to automatically adjust insulin delivery based on blood glucose levels.
Bigfoot Unity Diabetes Management System: This diabetes management system is designed to automate insulin delivery for people with type 2 diabetes. The system includes a CGM sensor, an insulin pump, and a cloud-based algorithm.
Senseonics Eversense CGM System: This CGM system is an implantable device that measures glucose levels in the interstitial fluid. The sensor is inserted under the skin and can transmit glucose data to a compatible smartphone for up to 90 days.
Zoey Health Digital Diabetes Assistant: This digital diabetes assistant is a mobile app that provides personalized support to people with diabetes. The app uses AI to track blood glucose levels, provide medication reminders, and offer personalized recommendations.
The Accu-Chek Guide Blood Glucose Monitoring System by Roche Diabetes Care Saudi Arabia is a reliable and user-friendly device designed to help individuals with diabetes manage their blood glucose levels effectively. This system provides accurate and fast results, with a small blood sample size and easy-to-read display.
The Dexcom G6 Continuous Glucose Monitoring System is a state-of-the-art medical device designed to help individuals with diabetes manage their condition effectively. Operating in Saudi Arabia, the system continuously tracks glucose levels with a small sensor placed under the skin, eliminating the need for fingersticks.
Increasing diabetes patients, drug development in the field of diabetes, presence of generic drugs, government support, technological advancement, rising geriatric population, rising awareness and increasing healthcare and expenditure are the factors that are driving the diabetes market.
The Saudi Arabian government is investing heavily in improving the country’s healthcare infrastructure. This includes building new hospitals and clinics, and investing in new medical technologies. These investments are making it easier for people with diabetes to access the care they need, and are also driving demand for diabetes medical devices.
The Saudi Arabia diabetes medical device market is a dynamic and growing market. The increasing prevalence of diabetes, the growing awareness of diabetes management, and the improving healthcare infrastructure are all driving demand for diabetes medical devices.
Diabetes medical devices can be expensive, which can limit access to care for some people with diabetes. This is particularly true for innovative and advanced devices, such as continuous glucose monitoring (CGM) systems and insulin pumps. The high cost of these devices can make them unaffordable for many people with diabetes, especially those with limited financial resources.
3.
Senseonics and Abbott Laboratories
Partnership to develop and commercialize a co-branded implantable CGM system using Senseonics’ Eversense sensor and Abbott’s Freestyle Libre reader.
SAUDI ARABIA DIABETES MEDICAL DEVICE MARKET SEGMENTATION
